Hybrid nanozymes with synergetic catalytic activity as antimicrobial agents

Antimicrobial resistance (AMR) is an escalating global health crisis, with projections indicating it could cause up to 39 million deaths over the next 25 years, equivalent to more than three deaths every minute. My research focuses on the development of hybrid nanozymes, which are nanoparticles engineered to mimic natural enzymes and generate reactive oxygen molecules capable of destroying bacteria, including drug-resistant strains. By integrating metals and metal oxides, these hybrid nanozymes leverage a synergistic effect to amplify their catalytic and antimicrobial activity. This approach offers a promising, and cost-effective alternative to traditional antibiotics in the ongoing fight against resistant pathogens.